Drug Eluting Stent Registry of Thrombosis (DESERT)

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Medstar Research Institute

ClinicalTrials.gov Identifier:

NCT00812552

First received: December 18, 2008

Last updated: April 22, 2013

Last verified: April 2013

History of Changes

Tracking Information
First Received Date ^ICMJE	December 18, 2008
Last Updated Date	April 22, 2013
Start Date ^ICMJE	September 2009
Primary Completion Date	May 2012 (final data collection date for primary outcome measure)
Current Primary Outcome Measures ^ICMJE (submitted: December 18, 2008)	To assess for potential correlates surrounding subjects and lesions among patients that experience late or very late drug-eluting stent thrombosis [ Time Frame: Baseline ] [ Designated as safety issue: No ]
Original Primary Outcome Measures ^ICMJE	Same as current
Change History	Complete list of historical versions of study NCT00812552 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures ^ICMJE	Not Provided
Original Secondary Outcome Measures ^ICMJE	Not Provided
Current Other Outcome Measures ^ICMJE	Not Provided
Original Other Outcome Measures ^ICMJE	Not Provided

Descriptive Information
Brief Title ^ICMJE	Drug Eluting Stent Registry of Thrombosis
Official Title ^ICMJE	Drug Eluting Stent Registry of Thrombosis
Brief Summary	Multicenter, case-control study, to collect data regarding incidences of late and very late drug-eluting stent thrombosis with the aim of identifying trends and possible correlates of stent thrombosis.
Detailed Description	Not Provided
Study Type ^ICMJE	Observational
Study Design ^ICMJE	Observational Model: Case Control Time Perspective: Retrospective
Target Follow-Up Duration	Not Provided
Biospecimen	Not Provided
Sampling Method	Non-Probability Sample
Study Population	Patients, male or female, over 18 years of age, who are either known to have experienced late or very late drug-eluting stent thrombosis (Case), or have undergone drug-eluting stent implantation at the same facility, in the same time period as a matched Case Subject, and have not experienced drug-eluting stent thrombosis (Control).
Condition ^ICMJE	Coronary Artery Disease
Intervention ^ICMJE	Not Provided
Study Group/Cohort (s)	Case Late or very late drug-eluting stent thrombosis Control No drug-eluting stent thrombosis
Publications *	Not Provided
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Completed
Enrollment ^ICMJE	984
Completion Date	May 2012
Primary Completion Date	May 2012 (final data collection date for primary outcome measure)
Eligibility Criteria ^ICMJE	Inclusion Criteria: Patients over 18 years of age Case Subjects: patients who have experienced definite late or very late drug-eluting stent thrombosis Control Subjects: patients who underwent drug-eluting stent implantation at the same facility and in the same time period as a matched Case Subject, and have not experienced drug-eluting stent thrombosis. Exclusion Criteria: Patients not meeting the above Inclusion Criteria
Gender	Both
Ages	18 Years and older
Accepts Healthy Volunteers	No
Contacts ^ICMJE	Contact information is only displayed when the study is recruiting subjects
Location Countries ^ICMJE	United States, Canada, Switzerland

Administrative Information
NCT Number ^ICMJE	NCT00812552
Other Study ID Numbers ^ICMJE	DESERT
Has Data Monitoring Committee	Not Provided
Responsible Party	Medstar Research Institute
Study Sponsor ^ICMJE	Medstar Research Institute
Collaborators ^ICMJE	Not Provided
Investigators ^ICMJE	Not Provided
Information Provided By	Medstar Research Institute
Verification Date	April 2013
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top